Anti-VEGF combined with Verteporfin photodynamic therapy in age-related macular degeneration(AMD)

Anti-VEGF combined with Verteporfin photodynamic therapy in age-related macular degeneration(AMD) - Conbination therapy for AMD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002128

Enrollment

200

Registered

2009-06-29

Start date

2007-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age-related Macular Degeneration

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: cases with age-related macular degeneration

Exclusion criteria

Exclusion criteria: subjects with systemic risk factors

Design outcomes

Primary

Measure	Time frame
visual acuity, fundus examination including FA, IA and optical coherence tomography(OCT).	—

Secondary

Measure	Time frame
general examination of ocular findings	—

Countries

Japan

Contacts

Public ContactHidetoshi Yamashita

Yamagata University Hospital Department of Ophthalmolgy

shionhaneda055@gmail.com023-628-5374

Outcome results